Prevalence and impact of depression in cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 6, 2008, Pages 582-588

  Quittner, Alexandra L ^a   Barker, David H ^a   Snell, Carolyn ^a   Grimley, Mary E ^a   Marciel, Kristen ^a   Cruz, Ivette ^a  

^a Department of Biology   (United States)

Author keywords

Cystic fibrosis; Depression; Health related quality of life; Psychological intervention

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

CAREGIVER; CHRONIC DISEASE; COGNITIVE THERAPY; CYSTIC FIBROSIS; DEPRESSION; FAMILY FUNCTIONING; HUMAN; PARENT; PATIENT COMPLIANCE; PREVALENCE; PSYCHOLOGIC TEST; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; RISK FACTOR; SCREENING TEST; SUICIDAL IDEATION;

ADOLESCENT; CHILD; CYSTIC FIBROSIS; DEPRESSION; HUMANS; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SICKNESS IMPACT PROFILE;

EID: 55149114403     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283121cf1     Document Type: Review

References (90)

1. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005; 58:175-189.
2. Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health 2005; 95:998-1000.
3. Hermann C. International experiences with the hospital anxiety and depression scale: a review of validation data and clinical results. J Psychosom Res 1997; 42:17-41.
4. Nici L, Donner C, Wouters E, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Grit Care Med 2006; 173:1390-1413.
5. Whittemore R, Kanner S, Singleton S, et al. Correlates of depressive symptoms in adolescents with type 1 diabetes. Pediatr Diabetes 2002; 3:135-143.
6. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160:2101-2107.
7. Dowson CA, Kuijer RJ, Mulder RT. Anxiety and self-management behaviour in chronic obstructive pulmonary disease: what has been learned? Chron Respir Dis 2004; 1:213-220.
8. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res 2002; 53:859-863.
9. Bender BG. Risk taking, depression, adherence, and symptom control in adolescents and young adults with asthma. Am J Respir Grit Care Med 2006; 173:953-957.
10. Cystic Fibrosis Foundation. Patient Registry 2006. Bethesda, MD; 2008 Annual Report.
11. Quittner AL, Opipari LC, Espelage DL, et al. Role strain in couples with and without a child with a chronic illness: associations with marital satisfaction, intimacy, and daily mood. Health Psychol 1998; 17:112-124.
12. Kovacs M. The children's depression inventory (CDI). Psychopharmacol Bull 1985; 21:995-998.
13. Reynolds WM. Reynold child depression scale. Odessa, Florida: Psychological Assessment Resources; 1989.
14. Beck JS, Beck AT, Jolly J. Beck Youth Inventories of emotional and social impairment. San Antonio, Texas: Psychological Corporation; 2001.
15. Lang M, Tisher M. Children's depression scale. Victoria, Australia: Australian Council for Educational Research; 1978.
16. Berndt DJ, Kaiser CF. Multiscore depression inventory for children manual. Los Angeles, California: Western Psychological Services; 1996.
17. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67:361-370.
18. Reynolds WM. Reynolds adolescent depression scale: professional manual. 2nd ed. Lutz, Florida: Psychological Assessment Resources; 2002.
19. Weissman M, Orvaschell H, Padian N. Children's symptom and social functioning: self-report scales. J Nerv Ment Dis 1980; 168:736-740.
20. Radloff LS. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401.
21. Beck AT, Steer RA, Brown GK. BDI-II, Beck depression inventory: manual. 2nd ed. Boston: Harcourt Brace; 1996.
22. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry 1965; 12:63-70.
23. Berndt DJ, Petzel TP, Berndt SM. Development and initial evaluation of a multiscore depression inventory. J Pers Assess 1980; 44:396-403.
24. Weissman M, Prusoff B, Newberry P. Comparison of the CES-D with standardized depression rating scales at three points in time [technical report]. Yale University; 1975.
25. Stone WL, Lemanek K. Developmental issues in children's self-reports. In: Harter S, La Greca A, editors. Through the eyes of a child. Boston: Allyn & Boston; 1990.
26. Holmbeck GN, Thill WA, Bachanas P, et al. Evidence-based assessment in pediatric psychology: measures of psychosocial adjustment and psychopathology. J Pediatr Psychol 2007 [Epub ahead of print]. A review of measures to screen for depression and psychopathology in children and adolescents.
27. Sharp LK, Lipsky MS. Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician 2002; 66:1001-1007.
28. Bregnballe V, Thastum M, Shiotz PO. Psychosocial problems in children with cystic fibrosis. Acta Paediatr 2007; 96:58-61. Most recent study reporting on rates of depression and anxiety in children with CF.
29. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571.
30. Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the national epidemiologic survey on alcoholism and related conditions. Arch Gen Psychiatry 2005; 62:1097-1106.
31. Birmaher B, Ryan ND, Williamson DE. Depression in children and adolescents: clinical features and pathogenesis. In: Shulman KI, Tohen M, Kutcher S, editors. Mood disorders across the life span. New York: Wiley-Liss; 1996. pp. 51-82
32. Substance Abuse and Mental Health Services Administration. Results from the 2004 National Survey on Drug Use and Health: National Findings. Rockville, Maryland: Office of Applied Studies, NSDUH Series H-28; 2005.
33. Lewinsohn PM, Hyman H, Roberts RE, et al. Adolescent psychpathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol 1993; 102:133-144.
34. Costello EJ, Foley DL, Angold A. 10-year research update review: the epidemiology of child and adolescent psychiatric disorders: II. Developmental epidemiology. J Am Acad Child Adolesc Psychiatry 2006; 45:8-25.
35. Stewart SM, Rao U, White P. Depression and diabetes in children and adolescents. Curr Opin Pediatr 2005; 17:626-631.
36. Hood KK, Huestis S, Maher A, et al. Depressive symptoms in children and adolescents with type 1 diabetes: association with diabetes-specific characteristics. Diabetes Care 2006; 29:1389-1391.
37. Goodwin RD, Fergusson DM, Horwood U. Asthma and depressive and anxiety disorders among young persons in the community. Psychol Med 2004; 34:1465-1474.
38. Jaser SS, Whittemore R, Ambrosino JM, et al. Mediators of depressive symptoms in children with type 1 diabetes and their mothers. J Pediatr Psychol 2008; 33:509-519.
39. Bush T, Richardson L, Katon W, et al. Anxiety and depressive disorders are associated with smoking in adolescents with asthma. J Adolesc Health 2007; 40:425-432.
40. Richardson LP, Lozano P, Russe J, et al. Depression symptoms asthma symptom burden: relationship to asthma severity and anxiety and heightened risk in chronic illness. Pediatrics 2006; 118:1042-1051.
41. Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007; 132:231-237. This study provides the most up to date rate of depression in adults with CF. This study also evaluates the relationship between depression, lung function, and quality of life.
42. Pfeffer PE, Pfeffer JM, Hodson ME. The psychosocial and psychiatric side of cystic fibrosis in adolescents and adults. J Cyst Fibros 2003; 2:61-68.
43. Pearson DA, Pumariega AJ, Seilheimer DK. The development of psychiatric symptomatology in patients with cystic fibrosis. J Am Acad Child Adolesc Psychiatry 1991; 30:290-297.
44. Riekert KA, Boyle MP, Rand CS. Gender, depression, lung function, and quality of life among adults with CF. Pediatr Pulmonol 2004; S27: 356.
45. Anderson DL, Flume PA, Hardy KK. Psychological functioning of adults with cystic fibrosis. Chest 2001; 119:1079-1084.
46. Thompson RJ Jr, Hodges K, Hamlett KW. A matched comparison of adjustment in children with cystic fibrosis and psychiatrically referred and non-referred children. J Pediatr Psychol 1990; 15:745-759.
47. Thompson RJ Jr, Gustafson KE, Hamlett KW, Spock A. Psychosocial adjustment of children with cystic fibrosis: the role of child cognitive processes and maternal adjustment. J Pediatr Psychol 1992; 17:741-755.
48. Quittner AL, DiGirolamo AM, Michel M, Eigen H. Parental response to cystic fibrosis: a contextual analysis of the diagnosis phase. J Pediatr Psychol 1992; 17:683-704.
49. Glasscoe C, Lancaster GA, Smyth RL, Hill J. Parental depression following the early diagnosis of cystic fibrosis: a matched, prospective study. J Pediatr 2007; 150:185-191. This study assesses the impact of a CF diagnosis on parents' emotional functioning.
50. Ylmaz O, Sogut A, Guile S, et al. Sleep quality and depression-anxiety in mothers of children with two chronic respiratory diseases: asthma and cystic fibrosis. J Cyst Fibros 2008 [Epub ahead of print].
51. Quittner AL, Slater S. Parenting stress, depression, and caregiving for young children with cystic fibrosis. Pediatr Pulmonol 2005; 28:180-181.
52. Rubin RR, Peyrot M. Psychosocial problems and interventions in diabetes. A review of the literature. Diabetes Care 1992; 15:1640-1657.
53. Rubin DH, Bauman LJ, Lauby JL. The relationship between knowledge and reported behavior in childhood asthma. J Dev Behav Pediatr 1989; 10:307-312.
54. Simoni JM, Asamow JR, Munford PR, et al. Psychological distress and treatment adherence among children on dialysis. Pediatr Nephrol 1997; 11:604-606.
55. Bartlett SJ, Krishnan JA, Riekert KA, et al. Maternal depressive symptoms and adherence to therapy in Inner-city children with asthma. Pediatrics 2004; 113:229-237.
56. Wood RA. Pediatric Asthma. JAMA 2002; 288:745-747.
57. Lin EHB, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27:2154-2160.
58. Lustman PJ, Clouse RE, Ciechanowski PS, et al. Depression-related hyper-glycemia in type 1 diabetes: a mediational approach. Psychosom Med 2005; 67:195-199.
59. Quittner AL, Barker DH, Geller D, et al. Effects of maternal depression on electronically monitored enzyme adherence and changes in weight for children with CF [abstract]. J Cyst Fibres 2007; 6:77.
60. Smith BA, Wood BL. Psychological factors affecting disease activity in children and adolescents with cystic fibrosis: medical adherence as a mediator. Curr Opin Pediatr 2007; 19:553-558. Reviews the influence of psychiatric, psychological, emotional, and family factors on treatment adherence and health outcomes.
61. Szyndler JE, Towns SJ, van Asperen PP, McKay KO. Psychological and family functioning and quality of life in adolescents with cystic fibrosis. J Cyst Fibros 2005; 4:135-144.
62. Spieth LE, Stark LJ, Mitchell MJ, et al. Observational assessment of family functioning at mealtime in preschool children with cystic fibrosis. J Pediatr Psychol 2001; 26:215-224.
63. McClellan CB, Cohen LL Family functioning in children with chronic illness compared with healthy controls: a critical review. J Pediatr 2007; 150:221-223.
64. Quittner AL, Opipari LC, Regoli MJ, et al. The impact of caregiving and role strain on family life: comparisons between mothers of children with cystic fibrosis and matched controls. Rehabil Psychol 1992; 37:289-304.
65. Burker EJ, Sedway J, Carone S. Psychological and educational factors: better predictors of work status than FEV1 in adults with cystic fibrosis. Pediatr Pulmonol 2004; 38:413-418.
66. Quittner AL, Buu A, Messer MA, et al. Development and validation of the Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005; 128:2347-2354.
67. Lavoie KL, Bacon SL, Barone S, et al. What is worse for asthma control and quality of life: depressive disorders, anxiety disorders, or both? Chest 2006; 130:1039-1047.
68. Johnson EK, Jones JE, Seidenberg M, Hermann BP. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004; 45:544-550.
69. Carels R. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res 2004; 13:63-72.
70. Cully JA, Graham DP, Stanley MA, et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006; 47:312-319.
71. Williams JW Jr, Katon W, Un EHB, et al. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004; 140:1015-1024.
72. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema, Int J Clin Pract 2006; 60:984-992.
73. Vetter TR. A clinical profile of a cohort of patients referred to an anesthesiology-based pediatric chronic pain medicine program. Anesth Analg 2008; 106:786-794.
74. Janicke DM, Marciel KK, Ingerski LM, et al. Impact of psychosocial factors on quality of life in overweight youth. Obesity 2007; 15:1799-1807.
75. Cohen M, Mansoor D, Langut H, Lorber A. Quality of life, depressed mood, and self-esteem in adolescents with heart disease. Psychosom Med 2007; 69:313-318.
76. Cuijpers P, Van Strafen A, Warmerdam L, Smits N. Characteristics of effective psychological treatments of depression: a metaregression analysis. Psychother Res 2008; 18:225-236.
77. Treatment for adolescents with depression study team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: treatment for adolescents with depression study (TADS) randomized controlled trial. JAMA. 2004; 292:807-820.
78. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006; 132:132-149.
79. Deshauer D, Moher D, Fergusson D, et al. Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials. CMAJ 2008; 178:1293-1301.
80. de Maat SM, Dekker J, Schoevers RA, de Jonghe F. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis. Eur Psychiatry 2007; 22:1-8.
81. U.S. Food and Drug Administration. Worsening depression and suicidality in patients treated with antidepressant medications. 2004; http://www.fda.gov/ cder/drug/antidepressants/AntidepressanstPHA.htm. [Accessed May 22 2008]
82. Bostic JQ, Rubin DH, Prince J, Schlozman S. Treatment of depression in children and adolescents. J Psychiatr Pract 2005; 11:141-154.
83. Kapornai K, Vetro A. Depression in children. Curr Opin Psychiatry 2008; 21:1-7.
84. Kilbourne AM, Daugherty B, Pincus HA. What do general medical guidelines say about depression care? Depression treatment recommendations in general medical practice guidelines. Curr Opin Psychiatry 2007; 20:626-631.
85. Caron A, Weissman MM. Interpersonal psychotherapy in the treatment of depression in medical patients. Prim Psychiatry 2006; 13:43-50.
86. Cuijpers P, van Strafen A, Warmerdam L. Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev 2007; 27:318-326. Reviews the effectiveness of an abbreviated, less technical component of psychotherapy that may be easier to integrate into busy health-care clinics
87. Duff AJA. Psychological interventions in cystic fibrosis and asthma. Paediatr Respir Rev 2001; 2:350-357.
88. Glasscoe CA, Quittner AL Psychological interventions for cystic fibrosis. Cochrane Database Syst Rev 2003:CD003148.
89. Quittner AL, Schlechter M. Prevalence and impact of depression and anxiety in CF patients and caregivers. Bethesda, Maryland, USA: Cystic Fibrosis Foundation; 2007.
90. Kates N, Mach M. Chronic disease management for depression in primary care: a summary of the current literature and implications for practice. Can J Psychiatry 2007; 52:77-85.